Category: Technology Licenses
Created On: 2022-04-28
Record Count: 7
- Drug Discovery
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 209536
This agreement is relative to the supply of nucleoside phosphoramidites and the sale by Licensee to third parties of oligonucleotides made from such nucleoside phosphoramidites.
4373071 Solid-Phase Synthesis of Polynucleotides
4401796 Sold Phase Synthesis Pol ynucleotides
4415732 Phosphoramidite Compounds and Processes
4458066 Process for Preparing Polynucleotides
4500707 Nudeosides Useful in the Preparation of Polynucleotides
4668777 Phosphoramidite Nucleoside Compounds
4973679 Process for Oligonucleotide Synthesis using
5047524 Automated System for Polynucleotide Synthesis and
5132418 Process for Preparing Polynucleotides
5153319 Process for Preparing Polynucleotides
5262530 Automated System for Polynucleotide Synthesis and
IPSCIO Record ID: 243464
For the Non-Exclusive License to Licensee for Instruments Developed Outside the Joint Development Program, Licensor grants a non-exclusive, world-wide license under Licensors interest in Collaboration Licensors Intellectual Property to make, have made, use, import, offer to sell, and sell instruments outside the Collaboration Field.
For the Non-Exclusive License to Licensee for Instruments, Licensor grants to a non-exclusive world-wide license under Licensors interest in the Intellectual Property to use, offer to sell, and sell Instruments outside of the Collaboration Field.
This agreement also includes exclusive grants from Licensee to Licensor.
Licensor has certain skills, proprietary technology and know-how related to the development of bioanalytical instrumentation systems and associated reagents and the marketing, sales and support of products incorporating such systems.
Licensor has DNA Synthesis and Purification Patents referred to as the Caruthers Process and Caruthers Reagents, and related patents.
Nucleic Acid Analysis Field means the field of characterization of a nucleic acid sample including but not limited to the determination of the relative abundance of the nucleic acid, all or part of a sequence of the nucleic acid, or variations in the sequence of the nucleic acid. The Nucleic Acid Analysis Field excludes the Collaboration Field.
The Parties are designing product based on the Array of Arrays for SNP genotyping. The first SNP genotyping assay format that Licensee intend to commercialize will be PE Biosystems' proprietary OLA ZipCode assay format. This assay format enables the creation of a universal Array of Arrays that can be used to analyze any set of SNPs.
IPSCIO Record ID: 314354
Licensor grants the Canadian Licensee a worldwide, nonexclusive license, with the right to grant sublicenses, under the Licensor Core Technology, Core Technology Patents, Manufacturing Technology and Manufacturing Patents to research, develop, make, have made, use, gain regulatory approval, commercialize, sell, offer for sale, have sold, export and import OGX-011 and Products for all uses.
For Development, Commercialization and Regulatory Responsibilities, Licensee will have sole responsibility, including without limitation sole responsibility for all funding, resourcing and decision making, for all further development and commercialization with respect to OGX-011 and Products.
OGX-011 is a second generation antisense inhibitor of Clusterin. Clusterin means the gene target, official symbol CLU, which is also referred to as Testosterone Repressed Prostatic Message -2 (TRPM-2), and Sulphated Glycoprotein2 (SGP-2).
Licensors Core Technology includes the patents and excludes the Manufacturing Technology and Product-Specific Technology.
IPSCIO Record ID: 329722
Licensor hereby grants to Licensee an option, exercisable on a Reagent Non-ASO Compound-by-Reagent Non-ASO Compound basis, to obtain a non-exclusive royalty-bearing licenses under the Licensor Blocking Patent Rights to develop, make, use, import, offer for sale and sell Reagent Non-ASO Products in the Territory; such license(s) shall include the right to grant sublicenses solely for the purpose of developing, making, using, importing, offering for sale and selling the applicable Reagent Non-ASO Product.
Licensor hereby grants to Licensee an option, exercisable on a Reagent Target-by-Reagent Target or Validation Target-by-Validation Target basis, as applicable, to obtain an exclusive, royalty-bearing license, including the right to sublicense, under the Licensor Collaboration Technology and the Licensor Technology to develop, make, use, import, offer for sale and sell Reagent ASO Products containing one or more Reagent ASO Compounds directed to such Reagent Target or Validation ASO Products containing one or more Validation ASO Compounds directed to such Validation Target, as applicable, in the Territory.
Licensor hereby grants to Licensee an exclusive option, exercisable on a Drug Discovery Target-by-Drug Discovery Target basis, to obtain an exclusive, royalty-bearing license, including the right to sublicense, under the Licensor Collaboration Technology and the Licensor Technology to develop, make, use, import, offer for sale and sell Drug Discovery ASO Products containing one or more Drug Discovery ASO Compounds directed to such Drug Discovery Target in the Territory.
U.S. Patent No. 6,069,243- Process for oligonucleotide synthesis
Field of use is for use in gene functionalization and target validation and as therapeutic products in the field of antisense technology, including processes and techniques relating to the design, synthesis and research of antisense oligonucleotides.
Non-ASO Field means the research, development, manufacture and sale of compounds other than ASO Compounds as therapeutic or prophylactic pharmaceutical products.
ASO Field means the development, manufacture and sale of ASO Products as therapeutic or prophylactic pharmaceutical products.
IPSCIO Record ID: 222537
The Invention shall mean a novel inkjet technology for the synthesis of oligonucleotides on glass or silicon surfaces that provides a proprietary solution with solvent that allows reagent delivery from the inkjet heads, referred to as Solvent and Apparatus for DNA Synthesis.
Licensed Subject Matter shall mean any subject matter, including but not limited to products and processes, covered in whole or in part by any issued, unexpired patent claim or a claim in a pending patent application contained in the Licensed Patents in the country in which said subject matter is made, used, or sold.
IPSCIO Record ID: 280323
Monomer Licensed Product shall mean a Licensed Product which is a monomer used in the synthesis of an oligonucleotide N3->P5 phosphoramidate.
Research Field shall mean any use in the field of scientific or commercial research, excepting any use that involves treating humans in any way whatsoever for any condition or any use that involves diagnosis of, testing for, or detection of, a disease condition, or the predisposition or susceptibility thereto, or the clinical progress thereof.
IPSCIO Record ID: 310347
6,399,335 – amma.-phosphoester nucleoside triphosphates
The field of use is in the medical industry relating to nucleoside which is a compound (e.g., adenosine or cytidine) commonly found in DNA or RNA, consisting of a purine or pyrimidine base linked to a sugar. In medicine several nucleoside analogues are used as antiviral or anticancer agents.
Field All uses of gamma-labeled nucleoside n-phosphates alone or in combination with other reagents in sequencing, enzyme analysis for sequence optimization and sequence analysis, specifically excluding the field of therapeutic administration of gamma-labeled nucleoside n-phosphates to a mammal.
Licensee develops, manufactures and markets an integrated platform for genetic analysis.